title: Liposomal doxorubicin in AIDS-related Kaposi's sarcoma.
authors.forename: U R
authors.initials: UR
authors.lastname: Hengge
authors.forename: N H
authors.initials: NH
authors.lastname: Brockmeyer
authors.forename: M
authors.initials: M
authors.lastname: Baumann
authors.forename: G
authors.initials: G
authors.lastname: Reimann
authors.forename: M
authors.initials: M
authors.lastname: Goos
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000328:Adult; D001853:Bone Marrow / Q000187:drug effects; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004361:Drug Tolerance; D006801:Humans; D008081:Liposomes; D009503:Neutropenia / Q000139:chemically induced; D012074:Remission Induction; D012307:Risk Factors; D012514:Sarcoma, Kaposi / Q000188:drug therapy* / Q000209:etiology*; D015996:Survival Rate
chemical_list: D008081:Liposomes; D004317:Doxorubicin